Number of patients | 88 | Location of tumor | 92 lesions |
Median age (range) | 64 (33–93) | Cerebral hemisphere | 61 |
Age ≥65 | 42 | Frontal | 27 |
Age <65 | 46 | Parietal | 10 |
Sex | Temporal | 13 | |
Male | 42 | Occipital | 21 |
Female | 46 | Thalamus, basal ganglia | 4 |
Primary cancer | Cerebellum | 17 | |
Lung | 41 | Median KPS score | 70 (50–100) |
Breast | 23 | KPS ≥70 | 54 |
Gastro-intestinal tract | 9 | KPS <70 | 34 |
Ovary | 4 | Tumor volume, median (cm3) | 16.2 |
Kidney | 3 | ≥ 30.0 | 13 |
Thyroid | 2 | 20.0-29.9 | 18 |
Larynx | 2 | 10.0-19.9 | 61 |
Uterus | 2 | Image follow-up period (months) | |
Others | 6 | Median | 7 |
Multiple vs single | Range | 1-37 | |
Multiple metastases | 45 | Survival period (months) | |
Single metastases | 43 | Median | 9 |
Metastases to other organs | 50 | Range | 3-41 |